Molecular mechanism and therapeutic implications of selinexor (KPT-330) in liposarcoma
10.18632/oncotarget.13485
Saved in:
Main Authors: | Garg, M, Kanojia, D, Mayakonda, A, Said, J.W, Doan, N.B, Chien, W, Ganesan, T.S, Chuang, L.S.H, Venkatachalam, N, Baloglu, E, Shacham, S, Kauffman, M, Koeffler, H.P |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
Impact Journals LLC
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/174903 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor
by: Subhash, V.V, et al.
Published: (2020) -
Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin
by: Garg, M, et al.
Published: (2020) -
Matrix metalloproteinase-1 facilitates MSC migration via cleavage of IGF-2/IGFBP2 complex
by: Guan, S.P, et al.
Published: (2020) -
Novel carfilzomib-based combinations as potential therapeutic strategies for liposarcomas
by: Jeitany, Maya, et al.
Published: (2022) -
A systematic review of margin status in retroperitoneal liposarcomas: does the R0 margin matter?
by: Paik, Benjamin, et al.
Published: (2022)